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The efficient use of testing resources is a key issue in the fight against doping. The
longitudinal tracking of sporting performances to identify unusual improvements possibly
caused by doping, so-called “athlete’s performance passport” (APP) is a new concept
to improve targeted anti-doping testing. In fact, unusual performances by an athlete
would trigger a more thorough testing program. In the present case report, performance
data is modeled using the critical power concept for a group of athletes based on
their past performances. By these means, an athlete with unusual deviations from his
predicted performances was identified. Subsequent target testing using blood testing
and the athlete biological passport resulted in an anti-doping rule violation procedure and
suspension of the athlete. This case demonstrates the feasibility of the APP approach
where athlete’s performance is monitored andmight serve as an example for the practical
implementation of the method.
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INTRODUCTION
The true prevalence of doping use in elite sports is unknown, but studies give estimates between
14 and 39% (de Hon et al., 2015). According to the World Anti-Doping Agency (WADA)’s
statistics, approximately 2% of the collected doping samples yearly are reported to contain a banned
substance. The figure remains quite stable despite the gradual increase of both, the number of
doping tests conducted and the sensitivity of the analytical methods (Marclay et al., 2013). Based
on these findings, a substantial discrepancy between the estimated prevalence of doping and the
number of positive doping cases remains.
The WADA is aware of the issue and demonstrates efforts toward its solution. One of the
major changes in recent years was the paradigm shift from purely chemical analyses and detection
of banned substances in biological samples to serial analysis of indirect biomarkers demonstrate
the usage of forbidden substances or methods. This culminated in concept of Athlete’s Biological
Passport (ABP) that longitudinally tracks certain biomarkers for features of doping (Sottas et al.,
2011). In addition to the sanctioning of more than 100 athletes based on their individual profiles,
the introduction of the ABP also resulted in an increased number of positive doping cases for
erythropoiesis stimulating agents (ESA) using traditional anti-doping methods, due to better test
targeting based on information from the ABP (Zorzoli and Rossi, 2012).
The original idea of “athlete’s performance profiling” or monitoring individual performances
for better informed decisions on doping testing has been presented by Schumacher and Pottgiesser
(2009). The main objective of performance profiling or “athlete performance passport” (APP)
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in sport is to distinguish between consistent and unexpectedly
disproportionate performances. Excellent performance itself is
not a proof of any wrongdoing or doping. However, through
longitudinal monitoring, inconsistently excellent performance
could be a warning sign that needs further attention from anti-
doping authorities.
The purpose of the present case report is to illustrate the
feasibility of this approach. In this example, the longitudinal
monitoring of performance identified a suspicious athlete who
was subsequently successfully target tested and convicted of an
anti-doping rule violation.
SUBJECTS AND METHODS
A pilot project was initiated for middle- and long-distance
runners by a National Anti-Doping Organization (NADO). The
athletes were included in the NADOs testing pool and its ABP
testing program. The rationale for inclusion in the registered
testing pool were based on athlete’s age, gender, ethnical
background, years of training, club, coach, and performance
level.
Individual APP were created for the athletes. The APP
consisted of all accessible competition results in long- and
middle-distance events. Results were gathered from an
open database www.tilastopaja.com. Based on the available
competition data, critical speed (CS) calculations (Vanhatalo
et al., 2011) were performed as follows in order to determine the
physiological capacities of each athlete.
The relationship between running speed and exercise duration
is the core of so-called critical power concept. The “critical
power” determines a performance (for instance running speed)
an athlete is able to sustain for a given amount of time. It is
expressed as the equation:
T = (D−W′)/CS
Where, T is time (s), D is the covered distance (m), W′ is
anaerobic work capacity (m), and CS is the CS (m/s). When
D and T are known for two distinct competitions, then W′
TABLE 1 | Athlete’s performance results calendar and calculations.
Day Competition Distance
(m)
Time (s) Average
Speed
(m/s)
Races used for
calculation of
CS
Predicted
CS (m/s)
Predicted
time (s)
Deviation of
competition
result from
prediction
(%)
1 Half-marathon 21,097.5 4,095 5.15 D1–D60 4.82 4,095 0
60 Road race 12,000 2,209 5.43 2,209 0
78 Marathon 42,195 8,450 4.98 8,469 +0.22
147 Half-marathon 21,097.5 4,438 4.75 D60–D78 4.84 4,089 −8.53
161 Half-marathon 21,097.5 4,214 5.01 4,089 −3.05
204 Road race 10,000 1,899 5.27 1,796 −5.76
239 Marathon 42,195 8,251 5.10 D161–D204 4.79 8,615 +4.22
and CS can be calculated. The previous competitions results
were used to predict performances at future events (running
speed/competition times over defined distances). After each
event, the results obtained in reality were compared to the
estimated performance and matched to the blood profile.
A number of factors, e.g., race tactics, pacing, and
environmental conditions, may affect final competition
results. Hence, Hopkins and Hewson have reported a possible
intra-individual variability of 1.0–1.4% in elite endurance
runners (Hopkins and Hewson, 2001). Timing for blood
testing was then individually adapted based on the competition
schedule and the results of the athletes. The written consent
and permission for this publication from the athlete was
acquired.
CASE REPORT
On day 1, the athlete reported in the present study ran a half-
marathon in a time close to his previous personal best i.e., 1 h
08min 15 s (seeTable 1). This result was in line with his historical
results over various distances in previous years.
The first blood sample was taken on day 45 of the
observational period as a routine out of competition test and,
for logistical reasons, the second test was only obtained on
day 86 (Figure 1). The discrepancy in hemoglobin, reticulocyte
parameters, and high OFF score between the first and second
samples raised attention and vigilance to follow his performances
closer. Analysis of competition results for the period between
the two blood sampling showed that at day 60 of the follow-
up athlete ran his personal best at the 12 km race (Table 1).
On day 78 the athlete achieved his best personal marathon
time (2 h 20min 50 s) which was in line with the calculated
predicted time i.e., 2 h 21min 8 s. This calculation was based on
the previous half-marathon time (day 1), and 12 km road race
time (day 60) (see Calculation 1 below). Further when choosing
distances for the calculations we divided results seasonally
into spring, summer and autumn trimesters and used the last
two competitions of the trimester for predictions of coming
trimester.
Frontiers in Physiology | www.frontiersin.org 2 March 2018 | Volume 9 | Article 280
Iljukov et al. Athlete’s Performance Passport for Doping Control
Calculation 1
Prediction of performance time Ti of distance 42,195m by
using length (m) of distance D1 = 21,097.5m and distance
D2 = 12,000m and performance time (s) of distances D1 and D2,
that is T1 4,095 and T2 2,209 s accordingly.
CS =
21, 097.5 − 12, 000
4, 095 − 2, 209
= 4.824 m/s
W′ =
12, 000 × 4, 095 − 21, 097.5 × 2, 209
4, 095− 2, 209
= 1, 344.44 m
T42,195 =
42, 195 − 1, 344.44
4.824
= 8, 468.2 s= 2 h 21 min 8 s
Following this event, the next three competition performances
between days 147 and 204 were also consistent with (or worse
than) predictions and without major discrepancies compared to
previous year’s results in the same competitions and no need for
further targeted testing was seen (Table 1, Figure 1). At the end
of the season however, on day 239, the athlete participated in an
international level marathon, where he finished again with a new
personal best time of 2 h 17min 31 s. Importantly, that with this
competition result, the athlete qualified for major international
competition and was selected for the national team. Based on
the athletes’ results of the latest half-marathon on day 161 and
the 10 km road race result on day 204, and using the critical
power concept, the athlete’s predicted time for the marathon was
calculated to be 2 h 23min 35 s (Calculation 2).
Calculation 2
CS =
21, 097.5− 10, 000
4, 214 − 1, 899
= 4.794 m/s
W′ =
10, 000 × 4, 214 − 21, 097.5× 1, 899
4, 214 − 1, 899
= 896.694 m
T42,195 =
42, 195 − 896.694
4.794
= 8, 614.6 s= 2 h 23 min 35 s
These races were chosen as less intra-individual variability
for road races and changes in physical performance within a
given timeframe are expected. Thus, the actual competition
time was markedly beyond predicted time with a difference
of 6min 4 s. This represented a deviation from prediction of
4.22% and was exceedingly better than would be expected.
At this point the decision to collect additional blood samples
for the purpose of the hematological profile of the ABP was
taken (Figure 1). Subsequent targeted samples for biological
passport (days 243 and 250) demonstrated clear features of blood
doping. Following IAAF disciplinary procedures, the athlete
admitted the anti-doping rule violation and was banned from
competition.
FIGURE 1 | On the horizontal axis, the observation period is pictured in days.
(A–D) The normalized deviation from the expected value based on CS
calculations (A) and the blood data of the athlete based on the adaptive model
of the ABP (B–D). In panel (A), a positive deviation indicates a better than
predicted performance. The red lines in panels (B–D) illustrate the individually
calculated reference limits of the ABP for each variable. The blue lines
represent the data.
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DISCUSSION
Optimally targeted anti-doping tests are crucial for the success
and the cost-efficiency ratio of any anti-doping program.
Considering the high number of athletes to be controlled by
National Anti-Doping Agencies it is crucial to prioritize and
direct anti-doping efforts primary to high risk groups and
individuals. Thus, decision on testing must involve multifactorial
risk assessment that includes a broad spectrum of information
(Schumacher and Pottgiesser, 2009; Saugy et al., 2011; Marclay
et al., 2013).
Considering that the main goal of doping is to improve
athlete’s performance, it seems reasonable to systematically
monitor athletes’ competition results for identification of possible
irregularities and initiation of additional anti-doping actions if
required. As the biological passport experience demonstrated,
in addition to sanctioning, longitudinal monitoring of athlete’s
blood parameters also helps to reveal suspicious traits that could
lead to targeted testing and cases of anti-doping rule violation
(Zorzoli and Rossi, 2012). Especially in the present case, where
themanipulation was likely the application of a blood transfusion
(visible in samples 5 and 6), correct timing of the tests is the
key. In fact, if the samples had not been obtained within a
certain timeframe, the typical features would not have been
visible anymore. With the anticipated competition schedule and
the previous results of the athlete at hand, it was much easier to
time the tests accordingly.
There is a lack of longitudinal studies on performance
changes over competitive season on highly trained runners. In
recent study Galbraith et al. (2014) found CS to be sensitive
and reliable measure of performance changes over competitive
season. There was statistically significant change in CS over
competitive season and tendency for change when evaluated on
84 day periods. When choosing races for calculations we divided
results seasonally into spring, summer, and autumn trimesters
and used the last two competitions of trimester for predictions
of the coming trimester. This division is somehow close to
84 days periods of Galbraith et al. study, thus allowing adjust
calculations even for slight changes in CS during competitive
season.
It must be stressed that any discrepancy between predicted
and actual competition performance should not be seen as an
indication of doping per se, as there are a number of factors
that obviously affect performance predictions andmeasurements.
Intra-individual variability in performance results might be
influenced by pacing, tactics, route of the race and environmental
conditions. Other factors that might impact performance, such
as tapering, are not taken into account in the current modeling,
as it assumed that these factors will be similar in all races.
The possibility of flawed competition data by previous doping
must also be considered. However, some important variation or
deviations of performance prediction are to be considered as
a “red flag” warning that needs further evaluation and closer
scrutiny from anti-doping authorities.
This case nevertheless demonstrates the rationale for an APP
and an example of its potential application for targeted doping
testing. The APP could be potentially used as an additional
tool together with the longitudinal monitoring of biological
parameters for improved targeting of suspicious athletes and
increasing the quality of anti-doping testing activities and thus
use available resources more efficiently. Although certainly not
the only existingmathematical model, the CS concept seems to be
a promising one to be used in the APP. There is urgent need for
further research on performance passport-related topic. A better
knowledge of inter- and intra-individual performance variability
or performance evolution during the whole athletic career is also
warranted for different sports and events in order to establish
meaningful alarm thresholds for the APP.
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